Should morbidity replace mortality as an endpoint for clinical trials in intensive care?-Reference-Cited by-同舟云学术

Should morbidity replace mortality as an endpoint for clinical trials in intensive care?

Published:1995-02 Issue:8946 Volume:345 Page:369-371
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Petros A.J.,Marshall J.C.,van Saene H.K.F.

Publisher

Elsevier BV

Subject

General Medicine

Reference22 articles.

1. Why have new therapies for sepsis not been developed?;Eidelman;Crit Care Med,1994

2. Anti-endotoxin antibodies: a dead end?;Cross;Ann Intern Med,1994

3. National estimates of intensive care utilization and costs: Canada and the United States;Jacobs;Crit Care Med,1990

4. Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension and hypothermia of gram negative sepsis;Alexander;J Clin Invest,1991

5. Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans;Romani;J Immunol,1994

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative evaluation of early treatment with ceftolozane/tazobactam versus ceftazidime/avibactam for non-COVID-19 patients with pneumonia due to multidrug-resistant Pseudomonas aeruginosa;Journal of Antimicrobial Chemotherapy;2024-09-11

2. Mortality As a Measure of Treatment Effect in Clinical Trials Recruiting Critically Ill Patients*;Critical Care Medicine;2023-01-20

3. Anti-cytokine Therapy in Critical Illness: Is There a Role?;Lessons from the ICU;2023

4. Blood Purification Studies in the ICU: What Endpoints Should We Use?;Blood Purification;2022

5. Incidence of morbidity and associated factors in a Pediatric Intensive Care Unit;Archivos Argentinos de Pediatria;2021-12-01